Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenofibrate in newly diagnosed pediatric type 1 diabetes
2020-003916-28Phase 2Active
- Sponsor
- Medical University of Warsaw
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Phenofibrate with Placebo (2 arms). Primary endpoint: Pancreatic beta-cell function assessed by stimulated C-peptide AUC. Started Jan 2021; status: active.
02
Drugs
fenofibrate
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2020-003916-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003916-28.